NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201520-03-2020
20-03-2020
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015.19-03-2020
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith copies of the newspaper publication of Un-audited Financial Results for the quarter and nine months ended December 31, 2019, published in Financial Express and Andhra Prabha on February 12, 2020 for your reference.12-02-2020
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Pursuant to Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Amit Agarwal, Chief Financial Officer of the Company, has tendered his resignation which would be effective from closing of the business hours on March 6, 2020, due to personal reasons.11-02-2020
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached a copy of the Press Release being issued by the Company and the same is being uploaded on the website of the Company.11-02-2020
Neuland Laboratories Ltd - 524558 - Corporate Action-Board approves Dividend
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations, 2015'), we wish to inform you that the Board of Directors at their meeting held on even date, i.e. February 11, 2020, has inter alia, declared and approved payment of Interim Dividend @ Rs.2.00/- (20%) per equity share of Rs. 10/- each for the Financial Year 2019-20. The Record Date for payment of Dividend is Feb 20, 2020. This is for your information and records.11-02-2020
Neuland Laboratories Ltd - 524558 - Outcome Of The Board Meeting - Un-Audited Standalone & Consolidated Financial Results For Quarter Ended December 31, 2019 & Interim Dividend For FY 2019-20
Pursuant to Regulation 30 and 33 of SEBI Listing Regulations, 2015, we wish to inform you that the Board of Directors at their meeting held on even date, i.e. February 11, 2020, has inter alia: i. approved the Un-audited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2019, which have been reviewed by the Audit Committee. ii. declared and approved payment of Interim Dividend @ Rs.2.00/- (20%) per equity share of Rs. 10/- each for the Financial Year 2019-20. iii. approved the re-appointment of Dr. Nirmala Murthy as Independent Director for a term of five years with effect from May 8, 2020, subject to the approval of the Members of the Company. Further, as earlier intimated, the Record date for the said Interim Dividend is Thursday, February 20, 2020.11-02-2020
Neuland Laboratories Ltd - 524558 - Board Meeting Update- Record Date For Payment Of Interim Dividend For FY 2019-20, Subject To Approval By The Board Of Directors Of The Company
We refer to our letter dated February 4, 2020, intimating that the meeting of the Board of Directors of the Company scheduled to be held on Tuesday, February 11, 2020, inter alia, shall consider declaration of interim dividend for the financial year 2019-20, if any, along with the Unaudited Financial Results for the quarter ended December 31, 2019 and 14th February, 2020 as the Record Date for payment of interim dividend, if any. Further to our afore-mentioned letter, we would like to inform you that the Record Date for the purpose of payment of interim dividend, if declared by the Board of Directors, shall be Thursday, February 20, 2020.04-02-2020
NEULAND LABORATORIES LTD. - 524558 - Corporate Action-Board to consider Dividend
We refer to our letter dated January 16, 2020, intimating that a meeting of the Board of Directors of the Company would be held on Tuesday, February 11, 2020, inter alia, to consider the Unaudited Financial Results of the Company for the quarter ended December 31, 2019. Further to the afore-mentioned letter, we would like to inform that the Board of Directors, at the Board Meeting scheduled on February 11, 2020, would, inter alia, also consider the declaration of interim dividend for the financial year 2019-20, if any, along with the Unaudited Financial Results for the quarter ended December 31, 2019. Pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015, we also inform you that subject to the afore-mentioned declaration by the Board of Directors, Friday, February 14, 2020, shall be the Record Date for the purpose of payment of interim dividend.04-02-2020